COVID-19 and Immunodeficiency

Corona viruses a type of virus that causes respiratory disorder such as the common cold to more   acute diseases such as Middle East Respiratory Syndrome (MERS) and Severe Acute Respiratory Syndrome (SARS). Majority of people with immune deficiencies and those on immune-suppressing drugs are immune compromised, putting them at a higher risk of respiratory diseases. The most common symptomatic primary immunodeficiency in adults is common element immunodeficiency. Affected patients do not establish an adequate humoral react to community-acquired viral illnesses, and recent researches have found evidence that these patients are more susceptible to severe SARS-CoV-2 infections. The injection of COVID-19 convalescent plasma could be varying in treatment technique in this case.

  • Primary immunodeficiency
  • SARS-CoV-2
  • COVID-19 convalescent plasma
  • Genetic defects
  • Covid-19 Alpha variant

  • Primary immunodeficiency
  • COVID-19 convalescent plasma
  • SARS-CoV-2
  • Genetic defects

Related Conference of COVID-19 and Immunodeficiency

January 03-04, 2023

International Congress on HIV-Aids and STD's

London, UK
February 15-16, 2023

11th World Summit on Immunology and Immunotherapy

Zurich, Switzerland
February 20-21, 2023

Global Summit on SARS-CoV-2 virus

Madrid, Spain
February 21-22, 2023

4th European Congress on Hematology

Zurich, Switzerland
May 24-25, 2023

37th International Conference on Immunology

Vienna, Austria

COVID-19 and Immunodeficiency Conference Speakers

Recommended Sessions

Related Journals

Are you interested in